The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Current state and challenges in developing oral vaccines
Open accessAbstract
While vaccination remains the most cost effective strategy for disease prevention, communicable diseases persist as the second leading cause of death worldwide. There is a need to design safe, novel vaccine delivery methods to protect against unaddressed and emerging diseases. Development of vaccines administered orally is preferable to traditional injection-based formulations for numerous reasons including improved safety and compliance, and easier manufacturing and administration. Additionally, the oral route enables stimulation of humoral and cellular immune responses at both systemic and mucosal sites to establish broader and long-lasting protection. However, oral delivery is challenging, requiring formulations to overcome the harsh gastrointestinal (GI) environment and avoid tolerance induction to achieve effective protection. Here we address the rationale for oral vaccines, including key biological and physicochemical considerations for next-generation oral vaccine design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
Peterson, L. W., & Artis, D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3608 · Cited by 3,173
Liposomes as nanomedical devices
Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,261
Larson, H. J., Jarrett, C., Eckersberger, E., Smith, D. M. D., & Paterson, P. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.081 · Cited by 2,254
Vaccine hesitancy: An overview
Dubé, E., Laberge, C., Guay, M., Bramadat, P., Roy, R., & Bettinger, J. A. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24657 · Cited by 2,172
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Stowman, K. (1949) · The Milbank Memorial Fund Quarterly · doi:10.2307/3348165 · Cited by 2,096
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Regional specialization within the intestinal immune system
Mowat, A. M., & Agace, W. W. (2014) · Nature Reviews Immunology · doi:10.1038/nri3738 · Cited by 1,756
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Holmgren, J., & Czerkinsky, C. (2005) · Nature Medicine · doi:10.1038/nm1213 · Cited by 1,562
Retinoic acid imprints gut-homing specificity on T cells
Iwata, M., Hirakiyama, A., Eshima, Y., Kagechika, H., Kato, C., & Song, S.-Y. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.011 · Cited by 1,541
Cone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Pelaseyed, T., Bergström, J. H., Gustafsson, J. K., Ermund, A., Birchenough, G. M. H., Schütte, A., van der Post, S., Svensson, F., Rodríguez‐Piñeiro, A. M., Nyström, E. E. L., et al. (2014) · Immunological Reviews · doi:10.1111/imr.12182 · Cited by 1,363
(2012) · Choice Reviews Online · doi:10.5860/choice.49-6620 · Cited by 1,273
Mucosal vaccines: the promise and the challenge
Neutra, M. R., & Kozlowski, P. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1777 · Cited by 1,223
Micro- and macrorheology of mucus
Lai, S. K., Wang, Y.-Y., Wirtz, D., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.012 · Cited by 1,223
Franchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.-D., Özören, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., et al. (2006) · Nature Immunology · doi:10.1038/ni1346 · Cited by 1,131
Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011984216775 · Cited by 1,097
The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo
Atuma, C., Strugala, V., Allen, A., & Holm, L. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.5.g922 · Cited by 1,078
Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria
Ayabe, T., Satchell, D. P., Wilson, C. L., Parks, W. C., Selsted, M. E., & Ouellette, A. J. (2000) · Nature Immunology · doi:10.1038/77783 · Cited by 1,060
Generation of Gut-Homing IgA-Secreting B Cells by Intestinal Dendritic Cells
Mora, J. R., Iwata, M., Eksteen, B., Song, S.-Y., Junt, T., Senman, B., Otipoby, K. L., Yokota, A., Takeuchi, H., Ricciardi-Castagnoli, P., et al. (2006) · Science · doi:10.1126/science.1132742 · Cited by 1,011
Vaccine adjuvants: Current state and future trends
Petrovsky, N., & Aguilar, J. C. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01272.x · Cited by 1,005
Epithelial antimicrobial defence of the skin and intestine
Gallo, R. L., & Hooper, L. V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3228 · Cited by 957
The mucosal immune system: from fundamental concepts to vaccine development
McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M., & Kiyono, H. (1992) · Vaccine · doi:10.1016/0264-410x(92)90021-b · Cited by 903
Child undernutrition, tropical enteropathy, toilets, and handwashing
Humphrey, J. H. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60950-8 · Cited by 862
Recent progress in mucosal vaccine development: potential and limitations
Lycke, N. (2012) · Nature Reviews Immunology · doi:10.1038/nri3251 · Cited by 807
Fu, K., Pack, D. W., Klibanov, A. M., & Langer, R. (2000) · Pharmaceutical Research · doi:10.1023/a:1007582911958 · Cited by 764
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 754
Uematsu, S., Fujimoto, K., Jang, M. H., Yang, B.-G., Jung, Y.-J., Nishiyama, M., Sato, S., Tsujimura, T., Yamamoto, M., Yokota, Y., et al. (2008) · Nature Immunology · doi:10.1038/ni.1622 · Cited by 745
Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium
Mabbott, N. A., Donaldson, D. S., Ohno, H., Williams, I. R., & Mahajan, A. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.30 · Cited by 721 · cited 2×
“M cells - <1% of total cells in the intestinal lumen -Cover lymphatic bodies, including lymphoid follicles and Peyer’s patches -Short microvilli and thin mucus layer -Heavily invaginated -Have a protruding glycocalyx -Efficient transcytosis activity -Antigen sampling -Active transportation of pathogens -Receptor-media…”
BackgroundProtein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles
van de Weert, M., Hennink, W. E., & Jiskoot, W. (2000) · Pharmaceutical Research · doi:10.1023/a:1026498209874 · Cited by 708
Approaches for enhancing oral bioavailability of peptides and proteins
Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.030 · Cited by 681 · cited 9×
“These characteristics can interfere with the delivery of fragile biomolecules, such as antigenic proteins or peptides, which are highly susceptible to degradation and denaturation [23].”
BackgroundInfluentialAdenoviruses as vaccine vectors
Tatsis, N., & Ertl, H. C. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.013 · Cited by 669
Strategies intended to address vaccine hesitancy: Review of published reviews
Dubé, E., Gagnon, D., & MacDonald, N. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.041 · Cited by 647
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development
Levine, M. M., Kaper, J. B., Black, R. E., & Clements, M. L. (1983) · Microbiological Reviews · doi:10.1128/mmbr.47.4.510-550.1983 · Cited by 636
Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response
Hase, K., Kawano, K., Nochi, T., Pontes, G. S., Fukuda, S., Ebisawa, M., Kadokura, K., Tobe, T., Fujimura, Y., Kawano, S., et al. (2009) · Nature · doi:10.1038/nature08529 · Cited by 632
Faria, A. M. C., & Weiner, H. L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00280.x · Cited by 601
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 594
Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches
Tsuji, M., Komatsu, N., Kawamoto, S., Suzuki, K., Kanagawa, O., Honjo, T., Hori, S., & Fagarasan, S. (2009) · Science · doi:10.1126/science.1169152 · Cited by 591
The intestinal epithelial stem cell
Marshman, E., Booth, C., & Potten, C. S. (2002) · BioEssays · doi:10.1002/bies.10028 · Cited by 586
Nanotechnology in vaccine delivery
Peek, L. J., Middaugh, C. R., & Berkland, C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.017 · Cited by 562
Vaccine delivery using nanoparticles
Gregory, A. E., Titball, R., & Williamson, D. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00013 · Cited by 561
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
Casella, C. R., & Mitchell, T. C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8228-6 · Cited by 560
Brannon-Peppas, L. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00324-x · Cited by 528
Liposomes as vaccine delivery systems: a review of the recent advances
Schwendener, R. A. (2014) · Therapeutic Advances in Vaccines · doi:10.1177/2051013614541440 · Cited by 525
Is the oral route possible for peptide and protein drug delivery?
Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.005 · Cited by 515 · cited 1×
“However, proteins are fragile structures and are easily denatured and degraded by changes in pH or presence of proteolytic enzymes [45, 89].”
BackgroundSelf-citationSurvey of the prevalence of immunization non-compliance due to needle fears in children and adults
Taddio, A., Ipp, M., Thivakaran, S., Jamal, A., Parikh, C., Smart, S., Sovran, J., Stephens, D., & Katz, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.011 · Cited by 498
GIUDICE, E., & CAMPBELL, J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.12.003 · Cited by 496
Physiological Parameters for Oral Delivery and in Vitro Testing
Mudie, D. M., Amidon, G. L., & Amidon, G. E. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100149j · Cited by 490
The intestinal epithelial stem cell: the mucosal governor
POTTEN, C. S., BOOTH, C., & PRITCHARD, D. M. (1997) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.1997.280362.x · Cited by 488
Cario, E., Gerken, G., & Podolsky, D. K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.015 · Cited by 475
Weiner, H. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10762 · Cited by 450
Environmental enteropathy: critical implications of a poorly understood condition
Korpe, P. S., & Petri, W. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.007 · Cited by 449
Yun, Y., Cho, Y. W., & Park, K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.007 · Cited by 444
Chitosan nanoparticles for oral drug and gene delivery
Bowman, K., & Leong, K. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.117 · Cited by 439
Gut instincts: Explorations in intestinal physiology and drug delivery
McConnell, E. L., Fadda, H. M., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.012 · Cited by 431
Casimiro, D. R., Chen, L., Fu, T.-M., Evans, R. K., Caulfield, M. J., Davies, M.-E., Tang, A., Chen, M., Huang, L., Harris, V., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6305-6313.2003 · Cited by 400
Vaccination Strategies for Mucosal Immune Responses
Ogra, P. L., Faden, H., & Welliver, R. C. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.430-445.2001 · Cited by 390
Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening
Yeh, T.-H., Hsu, L.-W., Tseng, M. T., Lee, P.-L., Sonjae, K., Ho, Y.-C., & Sung, H.-W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.056 · Cited by 379
Gut instincts: thoughts on intestinal epithelial stem cells
Booth, C., & Potten, C. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10229 · Cited by 369
Wang, J., Thorson, L., Stokes, R. W., Santosuosso, M., Huygen, K., Zganiacz, A., Hitt, M., & Xing, Z. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6357 · Cited by 359
Hydrogels and Scaffolds for Immunomodulation
Singh, A., & Peppas, N. A. (2014) · Advanced Materials · doi:10.1002/adma.201402105 · Cited by 355
Self-citationEmerging Trends in Oral Delivery of Peptide and Protein Drugs
Mahato, R. I., Narang, A. S., Thoma, L., & Miller, D. D. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.30 · Cited by 352
Strebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
Rationalizing the development of live attenuated virus vaccines
Lauring, A. S., Jones, J. O., & Andino, R. (2010) · Nature Biotechnology · doi:10.1038/nbt.1635 · Cited by 328
Gunawardene, A. R., Corfe, B. M., & Staton, C. A. (2011) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2011.00767.x · Cited by 311
Choonara, B. F., Choonara, Y. E., Kumar, P., Bijukumar, D., du Toit, L. C., & Pillay, V. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.006 · Cited by 311
des Rieux, A., Fievez, V., Théate, I., Mast, J., Préat, V., & Schneider, Y.-J. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.12.006 · Cited by 310
Shape and size-dependent immune response to antigen-carrying nanoparticles
Kumar, S., Anselmo, A. C., Banerjee, A., Zakrewsky, M., & Mitragotri, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.069 · Cited by 307
Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
Demento, S. L., Cui, W., Criscione, J. M., Stern, E., Tulipan, J., Kaech, S. M., & Fahmy, T. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.041 · Cited by 304
Vaccine adjuvants: Current challenges and future approaches
Wilson-Welder, J. H., Torres, M. P., Kipper, M. J., Mallapragada, S. K., Wannemuehler, M. J., & Narasimhan, B. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21523 · Cited by 296
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
Cholera vaccines: WHO position paper.
(2010) · PubMed · Cited by 286
Vaccine impact: Benefits for human health
Doherty, M., Buchy, P., Standaert, B., Giaquinto, C., & Prado- Cohrs, D. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.025 · Cited by 272
Antunes, F., Andrade, F., Araújo, F., Ferreira, D., & Sarmento, B. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.10.003 · Cited by 269
Enteropathies in the Developing World: Neglected Effects on Global Health
Prendergast, A., & Kelly, P. (2012) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.11-0743 · Cited by 260
Plotkin, S. A. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00290-09 · Cited by 256
Talaat, M., Kandeel, A., El-Shoubary, W., Bodenschatz, C., Khairy, I., Oun, S., & Mahoney, F. J. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.03.003 · Cited by 251
Vaccine technologies: From whole organisms to rationally designed protein assemblies
Karch, C. P., & Burkhard, P. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.001 · Cited by 251
Immunology of gut mucosal vaccines
Pasetti, M. F., Simon, J. K., Sztein, M. B., & Levine, M. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00970.x · Cited by 248
Belyakov, I. M., & Ahlers, J. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901466 · Cited by 244
A Replication-Defective Human Adenovirus Recombinant Serves as a Highly Efficacious Vaccine Carrier
XIANG, Z. Q., YANG, Y., WILSON, J. M., & ERTL, H. C. J. (1996) · Virology · doi:10.1006/viro.1996.0239 · Cited by 241
The American Psychiatric Publishing textbook of psychopharmacology
(2010) · Choice Reviews Online · doi:10.5860/choice.47-4164 · Cited by 233
Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine
Levine, M. M., Ferreccio, C., Abrego, P., Martin, O. S., Ortiz, E., & Cryz, S. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00231-5 · Cited by 228
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting
Brayden, D. J., Jepson, M. A., & Baird, A. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03536-1 · Cited by 224
New insights in mucosal vaccine development
Pavot, V., Rochereau, N., Genin, C., Verrier, B., & Paul, S. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.11.003 · Cited by 209
Conacher, M., Alexander, J., & Brewer, J. M. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00537-5 · Cited by 207
Vaccine Policy Changes and Epidemiology of Poliomyelitis in the United States
Alexander, L. N. (2004) · JAMA · doi:10.1001/jama.292.14.1696 · Cited by 203
Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Chen, H., Torchilin, V., & Langer, R. (1996) · Pharmaceutical Research · doi:10.1023/a:1016030202104 · Cited by 186
Bridging the knowledge gaps in vaccine design
Rappuoli, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1207-1361 · Cited by 185
Zhu, Q., Talton, J., Zhang, G., Cunningham, T., Wang, Z., Waters, R. C., Kirk, J., Eppler, B., Klinman, D. M., Sui, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2866 · Cited by 185
Liposomal delivery of antigen to human dendritic cells
Copland, M. J., Baird, M. A., Rades, T., McKenzie, J. L., Becker, B., Reck, F., Tyler, P. C., & Davies, N. M. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00536-4 · Cited by 184
Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells
Azizi, A., Kumar, A., Diaz-Mitoma, F., & Mestecky, J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001147 · Cited by 180
Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines
Demento, S. L., Siefert, A. L., Bandyopadhyay, A., Sharp, F. A., & Fahmy, T. M. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.02.004 · Cited by 176
Nochi, T., Yuki, Y., Matsumura, A., Mejima, M., Terahara, K., Kim, D.-Y., Fukuyama, S., Iwatsuki-Horimoto, K., Kawaoka, Y., Kohda, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070607 · Cited by 176
Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea
Sánchez, J., & Holmgren, J. R. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.06.007 · Cited by 174
Schimpel, C., Teubl, B., Absenger, M., Meindl, C., Fröhlich, E., Leitinger, G., Zimmer, A., & Roblegg, E. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400507g · Cited by 173
Effects of Flagellin on Innate and Adaptive Immunity
Honko, A. N., & Mizel, S. B. (2005) · Immunologic Research · doi:10.1385/ir:33:1:083 · Cited by 170
ISCOMTM‐based vaccines: The second decade
Sanders, M. T., Brown, L. E., Deliyannis, G., & Pearse, M. J. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01319.x · Cited by 166
The Intangible Value of Vaccination
Rappuoli, R., Miller, H. I., & Falkow, S. (2002) · Science · doi:10.1126/science.1075173 · Cited by 163
Delivery strategies to enhance oral vaccination against enteric infections
Davitt, C. J. H., & Lavelle, E. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.007 · Cited by 161
Pawar, V. K., Meher, J. G., Singh, Y., Chaurasia, M., Reddy, B. S., & Chourasia, M. K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.031 · Cited by 161
Gurwith, M., Lock, M. D., Taylor, E. M., Ishioka, G. Y., Alexander, J., Mayall, T., Ervin, J. E., Greenberg, R. N., Strout, C. B., Treanor, J. J., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70345-6 · Cited by 160
Wang, S., Liu, H., Zhang, X., & Qian, F. (2015) · Protein & Cell · doi:10.1007/s13238-015-0164-2 · Cited by 159
TLRs Regulate the Gatekeeping Functions of the Intestinal Follicle-Associated Epithelium
Chabot, S., Wagner, J. S., Farrant, S., & Neutra, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4275 · Cited by 158
Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination
Fievez, V., Plapied, L., des Rieux, A., Pourcelle, V., Freichels, H., Wascotte, V., Vanderhaeghen, M.-L., Jerôme, C., Vanderplasschen, A., Marchand-Brynaert, J., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.04.009 · Cited by 158
Oral delivery of nanoparticle-based vaccines
Marasini, N., Skwarczyński, M., & Tóth, I. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.936852 · Cited by 157
Catterina Ferreccio, R., Levine, M. M., Rodriguez, H., & Contreras, R. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.4.766 · Cited by 156
Human Intestinal M Cells Display the Sialyl Lewis A Antigen
Giannasca, P. J., Giannasca, K. T., Leichtner, A. M., & Neutra, M. R. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.946-953.1999 · Cited by 155
Perspectives on Mucosal Vaccines: Is Mucosal Tolerance a Barrier?
Mestecky, J. F., Russell, M. W., & Elson, C. O. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5633 · Cited by 151
Gut-associated lymphoid tissues for the development of oral vaccines
Kunisawa, J., Kurashima, Y., & Kiyono, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.07.003 · Cited by 150
A Recombinant Human Adenovirus Vaccine against Rabies
PREVEC, L., Campbell, J. B., Christie, B. S., Belbeck, L. W., & Graham, F. L. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.1.27 · Cited by 148
Black, R. E., Levine, M. M., Ferreccio, C., Clements, M. L., Lanata, C. F., Rooney, J., & Germanier, R. (1990) · Vaccine · doi:10.1016/0264-410x(90)90183-m · Cited by 145
Vaccines against mucosal infections
Holmgren, J. R., & Svennerholm, A. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.03.014 · Cited by 145
Sarti, F., Perera, G., Hintzen, F., Kotti, K., Karageorgiou, V., Kammona, O., Kiparissides, C. A., & Bernkop‐Schnürch, A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.011 · Cited by 144
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B
Gupta, P. N., Khatri, K., Goyal, A. K., Mishra, N., & Vyas, S. P. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701637982 · Cited by 136
Delivery systems for penetration enhancement of peptide and protein drugs: design considerations.
Kompella, U. B., & Lee, V. H. L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00137-x · Cited by 131
Targeting Nanoparticles to Dendritic Cells for Immunotherapy
Cruz, L. J., Tacken, P. J., Rueda, F., Domingo, J. C., Alberício, F., & Figdor, C. G. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391858-1.00008-3 · Cited by 131
Targeting polymerised liposome vaccine carriers to intestinal M cells
Clark, M. A., Blair, H. J., Liang, L., Brey, R. N., Brayden, D. J., & Hirst, B. H. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00258-4 · Cited by 130
Vaccine delivery carriers: Insights and future perspectives
Correia‐Pinto, J., Csaba, N., & Alonso, M. J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.047 · Cited by 122
Borges, O., Tavares, J., de Sousa, A., Borchard, G., Junginger, H. E., & Cordeiro‐da‐Silva, A. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.08.005 · Cited by 121
Pavot, V., Berthet, M., Rességuier, J., Legaz, S., Handké, N., Gilbert, S. C., Paul, S., & Verrier, B. (2014) · Nanomedicine · doi:10.2217/nnm.14.156 · Cited by 119
Jain, S., Harde, H., Indulkar, A. S., & Agrawal, A. K. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.08.012 · Cited by 113
Mucosal vaccines: novel advances in technology and delivery
Yuki, Y., & Kiyono, H. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.61 · Cited by 112
Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation
Tamayo, I., Irache, J. M., Mansilla, C., Ochoa‐Repáraz, J., Lasarte, J. J., & Gamazo, C. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00164-10 · Cited by 112
Control of adenovirus acute respiratory disease in U.S. Army trainees.
Fh, T. (1975) · PubMed · Cited by 111
PEG–PLA–PEG block copolymeric nanoparticles for oral immunization against hepatitis B
Jain, A., Goyal, A. K., Mishra, N., Vaidya, B., Mangal, S., & Vyas, S. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.12.013 · Cited by 111
Biswas, S., Chattopadhyay, M., Sen, K. K., & Saha, M. K. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.12.044 · Cited by 109
Delivery systems and adjuvants for oral vaccines
Lavelle, E. C., & O’Hagan, D. T. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.6.747 · Cited by 108
Bilosomes in the context of oral immunization: development, challenges and opportunities
Shukla, A., Mishra, V. K., & Kesharwani, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.03.013 · Cited by 108
Salman, H. H., Irache, J. M., & Gamazo, C. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.091 · Cited by 107
Viral Vaccination Via the Mucosal Routes
Ogra, P. L. O., Fishaut, M., & Gallagher, M. R. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.3.352 · Cited by 106
Single-injection vaccines: Progress, challenges, and opportunities
McHugh, K. J., Guarecuco, R., Langer, R., & Jaklenec, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.029 · Cited by 105
Administration strategies for proteins and peptides
Ibraheem, D., Elaïssari, A., & Fessi, H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.059 · Cited by 105
Towards tailored vaccine delivery: Needs, challenges and perspectives
Amorij, J., Kersten, G. F. A., Saluja, V., Tonnis, W. F., Hinrichs, W. L. J., Slütter, B., Bal, S. M., Bouwstra, J. A., Huckriede, A. L. W., & Jiskoot, W. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.039 · Cited by 104
Optimism over vaccines administered via mucosal surfaces
Levine, M. M., & Dougan, G. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79439-3 · Cited by 103
Russell-Jones, G. J. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00231-x · Cited by 103
Subsets of migrating intestinal dendritic cells
Milling, S. W. F., Yrlid, U., Cerovic, V., & MacPherson, G. G. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00866.x · Cited by 101
Characterization and optimization of bilosomes for oral vaccine delivery
Wilkhu, J. S., McNeil, S. E., Anderson, D. E., & Perrie, Y. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2012.747528 · Cited by 97
Hussain, N., & Florence, A. T. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981610840 · Cited by 94
Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery
Devriendt, B., Geest, B. G. D., Goddeeris, B. M., & Cox, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.006 · Cited by 94
Shukla, A., Katare, O. P., Singh, B., & Vyas, S. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.027 · Cited by 94
Mallapragada, S. K., & Narasimhan, B. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.030 · Cited by 94
Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization
Singh, P., Prabakaran, D. S., Jain, S., Mishra, V., Jaganathan, K. S., & Vyas, S. P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.014 · Cited by 90
Wang, N., Wang, T., Zhang, M., Chen, R., Niu, R., & Deng, Y. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.04.007 · Cited by 88
Durán‐Lobato, M., Carrillo‐Conde, B., Khairandish, Y., & Peppas, N. A. (2014) · Biomacromolecules · doi:10.1021/bm500588x · Cited by 86
Self-citationCurrent management of the gastrointestinal complications of systemic sclerosis
Emmanuel, A. V. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.99 · Cited by 85
Adipose Tissue Engineering Using Injectable, Oxidized Alginate Hydrogels
Kim, W. S., Mooney, D. J., Arany, P. R., Lee, K., Huebsch, N., & Kim, J. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0250 · Cited by 84
Digestion of Nucleic Acids Starts in the Stomach
Liu, Y., Zhang, Y., Dong, P., An, R., Xue, C., Ge, Y., Wei, L.-Z., & Liang, X. (2015) · Scientific Reports · doi:10.1038/srep11936 · Cited by 83
Liposomal Delivery of CTL Epitopes to Dendritic Cells
Chikh, G., & Schutze-Redelmeier, M.-P. M. (2002) · Bioscience Reports · doi:10.1023/a:1020151025412 · Cited by 79
Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice
Camacho, A. I., Irache, J. M., de Souza, J., Sánchez-Gómez, S., & Gamazo, C. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.020 · Cited by 79
Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?
Bobbala, S. K. R., & Hook, S. M. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1979-0 · Cited by 79
Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization
Gupta, P. N., & Vyas, S. P. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.08.027 · Cited by 78
Lycke, N. Y., & Bemark, M. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.54 · Cited by 78
Food-associated stimuli enhance barrier properties of gastrointestinal mucus
Yıldız, H., Speciner, L., Ozdemir, C., Cohen, D. E., & Carrier, R. L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.118 · Cited by 76
Summerton, N. A., Welch, R. W., Bondoc, L. L., Yang, H.-H., Pleune, B., Ramachandran, N. P., Harris, A. M., Bland, D., Jackson, W. J., Park, S., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.147 · Cited by 76
Jain, S., Sharma, R. K., & Vyas, S. P. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.3.0003 · Cited by 75
Liu, J., Wu, J., Wang, B., Zeng, S., Qi, F., Lu, C., Kimura, Y., & Liu, B. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23768 · Cited by 72
Advances and challenges in mucosal adjuvant technology
Newsted, D., Fallahi, F., Golshani, A., & Azizi, A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.096 · Cited by 72
Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin
Mann, J. F. S., Ferro, V. A., Mullen, A. B., Tetley, L., Mullen, M., Carter, K. C., Alexander, J. K., & STIMSON, W. H. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.067 · Cited by 71
Peters, W., Brandl, J. R., Lindbloom, J. D., Martínez, C., Scallan, C. D., Trager, G. R., Tingley, D. W., Kabongo, M. L., & Tucker, S. N. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.01.023 · Cited by 69
Parker, E. P. K., Molodecky, N. A., Pons-Salort, M., O’Reilly, K. M., & Grassly, N. C. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1052800 · Cited by 68
Raghavan, S., Hjulström, M., Holmgren, J. R., & Svennerholm, A. ‐. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6383-6388.2002 · Cited by 65
Harde, H., Agrawal, A. K., & Jain, S. (2014) · Nanomedicine · doi:10.2217/nnm.13.225 · Cited by 62
M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses
Lo, D. D., Ling, J., & Eckelhoefer, A. H. (2012) · BMC Biotechnology · doi:10.1186/1472-6750-12-7 · Cited by 62
He, X., Wang, F., Jiang, L., Li, ., Liu, S.-K., Xiao, Z., Jin, X.-Q., Zhang, Y., He, Y., Li, K., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.80575-0 · Cited by 60
Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann, J. F. S., Acevedo, R., del Campo, J. M., Pérez, O., & Ferro, V. A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.8.1.103 · Cited by 60
Dual role of commensal bacteria in viral infections
Wilks, J. C., Beilinson, H. A., & Golovkina, T. V. (2013) · Immunological Reviews · doi:10.1111/imr.12097 · Cited by 59
Zhou, D., Cun, A., Li, Y., Xiang, Z., & Ertl, H. C. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.027 · Cited by 57
Nayak, B., Panda, A. K., Ray, P., & Ray, A. R. (2009) · Journal of Microencapsulation · doi:10.1080/02652040802211709 · Cited by 57
Rational Design of Targeted Next-Generation Carriers for Drug and Vaccine Delivery
Narasimhan, B., Goodman, J. T., & Ramirez, J. E. V. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-082615-030519 · Cited by 57
TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces
Chabot, S. M., Chernin, T. S., Shawi, M., Wagner, J. S., Farrant, S. A., Burt, D. S., Cyr, S. L., & Neutra, M. R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.029 · Cited by 46
THE COSTS OF INTRODUCING A MALARIA VACCINE THROUGH THE EXPANDED PROGRAM ON IMMUNIZATION IN TANZANIA
Hutton, G., & Tediosi, F. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.119 · Cited by 46
Low-Dose Tolerance Is Mediated by the Microfold Cell Ligand, Reovirus Protein σ1
Rynda, A., Maddaloni, M., Złotkowska, D., Ochoa‐Repáraz, J., Maślanka, T., Crist, K., Riccardi, C., Barszczewska, B., Fujihashi, K., McGhee, J. R., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5187 · Cited by 45
A lipid based multi-compartmental system: Liposomes-in-double emulsion for oral vaccine delivery
Liau, J. J., Hook, S. M., Prestidge, C. A., & Barnes, T. J. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.09.018 · Cited by 44
Critchley-Thorne, R. J., Stagg, A. J., & Vassaux, G. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.011 · Cited by 43
Anatomy and physiology of the gastrointestinal tract
Graaff, K. M. V. D. (1986) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198601001-00005 · Cited by 42
Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy
Gessner, B. D., & Feikin, D. R. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.019 · Cited by 42
Roth-Walter, F., Bohle, B., Schöll, I., Untersmayr, E., Scheiner, O., Boltz-Nitulescu, G., Gabor, F., Brayden, D. J., & Jensen-Jarolim, E. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.03.020 · Cited by 42
Principles of Pharmacokinetics and Pharmacodynamics
DeVane, C. L. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585623860.as08 · Cited by 41
Complexation hydrogels as potential carriers in oral vaccine delivery systems
Yoshida, M., Kamei, N., Muto, K., Kunisawa, J., Takayama, K., Peppas, N. A., & Takeda‐Morishita, M. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.029 · Cited by 37
Self-citationKhurana, S., Coyle, E. M., Manischewitz, J. F., King, L. R., Ishioka, G. Y., Alexander, J., Smith, J., Gurwith, M., & Golding, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115476 · Cited by 25
Pang, Y., Zhang, Y., Wang, H., Jin, J., Piao, J., Piao, J., Liu, Q., & Li, W. (2013) · Avian Diseases · doi:10.1637/10427-101812-reg.1 · Cited by 22
Carreño, J. M., Perez‐Shibayama, C., Gil‐Cruz, C., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.05.036 · Cited by 20
Advances in Oral Vaccine Delivery Options
Webster, D. E., Gahan, M. E., Strugnell, R. A., & Wesselingh, S. L. (2003) · American Journal of Drug Delivery · doi:10.2165/00137696-200301040-00002 · Cited by 19
Thippeshappa, R., Tian, B., Cleveland, B., Guo, W., Polacino, P. S., & Hu, S.-L. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00597-15 · Cited by 15
Zhang, Q., Zhao, Q., Zhang, Y. Q., Han, N., Hu, L., Zhang, C., Jiang, T., & Wang, S. (2014) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.07.035 · Cited by 12
Bordin, A. I., & Cohen, N. D. (2015) · Wiley eBooks · doi:10.1002/9781119086512.ch29 · Cited by 10
Cited by
Enabling Technologies for Personalized and Precision Medicine
Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., Gelb, B. D., Ginsburg, G. S., Hassenstab, J., Ho, C.-M., et al. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.021 · Cited by 517
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 492
McClements, D. J. (2018) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2018.02.002 · Cited by 463
Advances in Oral Drug Delivery Systems: Challenges and Opportunities
Lou, J., Duan, H., Qin, Q., Teng, Z., Gan, F., Zhou, X., & Zhou, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020484 · Cited by 397
Yue, Y., Xu, J., Li, Y., Cheng, K., Feng, Q., Ma, X., Ma, N., Zhang, T., Wang, X., Zhao, X., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00886-2 · Cited by 264
Metadata
- Authors
- Vela Ramirez, J. E., Sharpe, L. A., & Peppas, N. A.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 114
- Pages
- 116-131
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2605753878
- Cited by
- 412
- References
- 194
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.